-
Mashup Score: 9“Must See” Abstracts at 2024 ASCO Annual Meeting - 7 month(s) ago
Keep an eye out for these top research studies highlighted by Cleveland Clinic leadership.
Source: consultqd.clevelandclinic.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 9“Must See” Abstracts at 2024 ASCO Annual Meeting - 7 month(s) ago
Keep an eye out for these top research studies highlighted by Cleveland Clinic leadership.
Source: consultqd.clevelandclinic.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 9“Must See” Abstracts at 2024 ASCO Annual Meeting - 7 month(s) ago
Keep an eye out for these top research studies highlighted by Cleveland Clinic leadership.
Source: consultqd.clevelandclinic.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 11
See the latest #BladderCancer live event from @PeerView @AndreaNecchi #ASCO24 #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 4Tour de Scottsdale - 8 month(s) ago
The Tour de Scottsdale is on Friday April 12, 2024 to Saturday April 13, 2024. It includes the following events: Adult Metric Century (62 Miles), Adult Half Metric Century (33 Miles), VIP Metric Century (62 Miles), VIP Half Metric Century (33 Miles), Bike Patrol (62 Miles), Bike Patrol (33 Miles), Youth Metric Century (62 Miles), Youth Half Metric Century (33 Miles), Military/First Responders Metric Century (62 Miles), Military/First Responders Half Metric Century (33 Miles), Youth Non-Profit Rider Metric Century (62 Miles), Youth Non-Profit Rider Half Metric Century (33 Miles), Adult Non-Profit Rider Metric Century (62 Miles), Adult Non-Profit Rider Half Metric Century (33 Miles), VIP Non-Profit Rider Metric Century (62 Miles), VIP Non-Profit Rider Half Metric Century (33 Miles), and USA Cycling PRIX RIDE & VIP Entry.
Source: www.tourdescottsdale.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 692023 Annual Report - 9 month(s) ago
Flipsnack is a digital catalog maker that makes it easy to create, publish and share html5 flipbooks. Upload a PDF or design from scratch flyers, magazines, books and more.
Source: www.flipsnack.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 42Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer - PubMed - 9 month(s) ago
PTEN LOF, identified with genomic testing, was associated with decreased survival and negative prognoses in patients with mCRPC.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 16
Don’t miss what’s happeningPeople on X are the first to know.Log inSign upSettingsPostMarkus Eckstein@Markuseckstein3FGFR3 mutations are frequent alterations in urothelial cancer, but : NMIBC: ~50% are mutated MIBC: ~10% are mutated UTUC stage independent: ~ 30% are mutated mUC (=bc + UTUC): ~15-20 % are mutated Fusions are very rare throughout all entities! Frequency is ~1% to…
Source: x.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 13
Don’t miss what’s happeningPeople on X are the first to know.Log inSign upSettingsPostMarkus Eckstein@Markuseckstein3FGFR3 mutations are frequent alterations in urothelial cancer, but : NMIBC: ~50% are mutated MIBC: ~10% are mutated UTUC stage independent: ~ 30% are mutated mUC (=bc + UTUC): ~15-20 % are mutated Fusions are very rare throughout all entities! Frequency is ~1% to…
Source: x.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 2
the 4th episode is out: in this cast we are starting the topic of muscle-invasive #urothelial #muscle invasive #bladdercancer! This post is just a short overview – there will be single post per topic! Most important fact upfront: MIBC is biologically completely different compared to pTa carcinomas! only a very low fraction of MIBC (
Source: x.comCategories: General Medicine News, Oncologists2Tweet
RT @jamecancerdoc: Outstanding panel of speakers and presenters from @ClevelandClinic @CleClinicMD at @ASCO @ASCO24 https://t.co/snGbtigoVz…